| 摘要 |
Methods of treating and/or preventing disorders mediated by one or more of TNF-alpha, NF-kappaB, IKK-alpha, IKK-beta, ATF-2 and p38 kinase by administration of praziquantel, or a pharmaceutically acceptable salt, prodrug, ester or amide thereof. These disorders include inflammatory disorders such as autoimmune diseases.
|
